tonice 10 mg ml 30 mg ml 40 mg ml xarope - hasil pencarian

extrovis eu ltd. - lacosamida - epilepsia - antiepilépticos, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Portugal - Portugis - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

depakine chronosphere 500 mg granulado de libertação modificada

sanofi - produtos farmacêuticos, lda. - Ácido valpróico - granulado de libertação modificada - 500 mg - Ácido valpróico 145.14 mg ; valproato de sódio 333.3 mg - valproic acid - n/a - duração do tratamento: longa duração

Portugal - Portugis - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

depakine chronosphere 500 mg granulado de libertação modificada